Cocrystal Pharma Inc COCP
NASDAQ · United States · Health Technology
$1.15+0.01 (+0.44%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.23 | -0.17 | -39.4% | $100.00K | — | 0.0%$1.12→$1.12 |
| Q1 2026 | 2026-05-15 | -0.17 | -0.15 | -13.3% | — | — | -6.3%$1.26→$1.18 |
| Q4 2025 | 2026-03-31 | -0.17 | -0.17 | 0.0% | — | — | +2.0%$1.00→$1.02 |
| Q3 2025 | 2025-11-14 | -0.19 | -0.21 | +9.5% | — | — | -1.0%$1.03→$1.02 |
| Q4 2024 | 2025-03-31 | -0.32 | -0.53 | +39.6% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.49 | -0.57 | +14.0% | — | — | — |
| Q1 2024 | 2024-05-13 | -0.39 | -0.56 | +30.4% | — | — | — |
| Q4 2023 | 2024-03-28 | -0.54 | -0.60 | +10.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.